Literature DB >> 17260150

Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set.

Corinne Behrend1, Florian Buchner, Michael Happich, Rolf Holle, Peter Reitmeir, Jürgen Wasem.   

Abstract

Five models of risk adjusters were tested as a (proxy) measure for health status with data from a large German sickness fund. The first two models use standard demographic and socio-demographic variables. One model incorporates a simple binary indicator for hospitalization and the last two are based on the hierarchical coexisting conditions (HCCs: DxCG Risk Adjustment Software Release 6.1) using in-patient diagnoses. Special investigations were done on the subgroups of insurees who left, joined or stayed with the fund over the observation period. Age and gender grouping accounted for 3.2% of the variation in total expenditure for concurrent as well as prospective models. The current German risk adjusters age, sex, and invalidity status account for 5.1 and 4.5% of the variance in the concurrent and prospective models, respectively. Age, gender, invalidity status and in-patient HCC covariates explain about 37% of the variations of the total expenditures in a concurrent model and roughly 12% of the variations of total expenditures in a prospective model. Only modest improvement can be achieved with the long-term-care (LTC) indicator. For high-risk (cost) groups, substantial under-prediction remains; conversely, for the low-risk group, represented by enrolees who did not show any health care expense in the base year, all of the models over-predict expenditure. Special investigations were done on the subgroups of insurees who left, joined or stayed with the fund over the observation period.

Entities:  

Mesh:

Year:  2007        PMID: 17260150     DOI: 10.1007/s10198-006-0004-7

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  3 in total

1.  Needs for further improvement: risk adjustment in the German health insurance system.

Authors:  Florian Buchner; Jürgen Wasem
Journal:  Health Policy       Date:  2003-07       Impact factor: 2.980

2.  Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population?

Authors:  A K Rosen; S Loveland; J J Anderson; J A Rothendler; C S Hankin; C C Rakovski; M A Moskowitz; D R Berlowitz
Journal:  Med Care       Date:  2001-07       Impact factor: 2.983

3.  Performance of diagnosis-based risk adjustment measures in a population of sick Australians.

Authors:  S J Duckett; P A Agius
Journal:  Aust N Z J Public Health       Date:  2002-12       Impact factor: 2.939

  3 in total
  6 in total

1.  Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.

Authors:  Conor Keegan; Conor Teljeur; Brian Turner; Steve Thomas
Journal:  Eur J Health Econ       Date:  2015-09-10

2.  Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years.

Authors:  S H C M van Veen; R C van Kleef; W P M M van de Ven; R C J A van Vliet
Journal:  Eur J Health Econ       Date:  2014-02-12

3.  Predictive risk modelling in the Spanish population: a cross-sectional study.

Authors:  Juan F Orueta; Roberto Nuño-Solinis; Maider Mateos; Itziar Vergara; Gonzalo Grandes; Santiago Esnaola
Journal:  BMC Health Serv Res       Date:  2013-07-09       Impact factor: 2.655

4.  A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems.

Authors:  Christin Juhnke; Susanne Bethge; Axel C Mühlbacher
Journal:  Int J Integr Care       Date:  2016-10-26       Impact factor: 5.120

Review 5.  Weight of Risk Factors for Adjusting Capitation in Primary Health Care: A Systematic Review.

Authors:  Ali Khezri; Alireza Mahboub-Ahari; Jafar Sadegh Tabrizi; Shirin Nosratnejad
Journal:  Med J Islam Repub Iran       Date:  2022-02-02

6.  Contract Design: Risk Management and Evaluation.

Authors:  Axel C Mühlbacher; Volker E Amelung; Christin Juhnke
Journal:  Int J Integr Care       Date:  2018-01-12       Impact factor: 5.120

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.